Latest / Morning Medical with Dr. Chow
Tirzepatide Advancements, GLP-1 Controversies, and Nasal Spray Epinephrine Breakthroughs
In today's episode, Dr. Chi-Ming Chow delves into the latest advancements in diabetes and weight loss treatments, starting with Eli Lilly's tirzepatide. He explains the drug's mechanism, effects, and considerations for long-term use. The episode also addresses emerging concerns regarding semaglutide and its potential mental health risks. Dr. Chow discusses the controversies and provides recommendations for GLP-1 drug prescriptions. Additionally, he explores the link between meat consumption and type 2 diabetes risk. The episode concludes with a breakthrough in allergy treatment: nasal spray…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.